Evaluation Of IKZF1 Δ4-7 Deletion As a Suitable Marker For Minimal Residual Disease Monitoring; A Study Of 161 Consecutive Acute Lymphoblastic Leukaemia (ALL) Patients On The On-Going UKALL14 Trial

被引：0
|
作者：
Zareian, Nahid
Patel, Bella
Rai-Shetty, Lena
Rowntree, Clare
McMillan, Andrew
Marks, David I.
Menne, Tobias
Smith, Paul
Purnell, Simon
Micklewright, Lynda
Moorman, Anthony V.
Fielding, Adele
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1335
引用
收藏
页数：2
相关论文
共 3 条
  • [1] IKZF1 as a novel marker of minimal residual disease in patients with acute lymphoblastic leukaemia
    Barkhatov, M.
    Lebedinova, N.
    Zagrivnaya, M.
    Semenova, E.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S247 - S248
  • [2] IKZF1Δ4-7 CAN BE EASILY SCREENED BY PCR BUT DOES NOT PREDICT OUTCOME IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA; DATA FROM 490 PATIENTS ENROLLED ON THE UKALL14 TRIAL
    Mitchell, R. J.
    Kirkwood, A. A.
    Wrench, B.
    Fearn, A.
    Schwab, C.
    Lawrie, E.
    Alapi, K. Zuborne
    Clifton-Hadley, L.
    Patrick, P.
    Naughton, T.
    Moorman, A. V.
    Fielding, A. K.
    HAEMATOLOGICA, 2017, 102 : 30 - 30
  • [3] IKZF1D4-7 can be easily screened by PCR but does not predict outcome in adults with acute lymphoblastic leukaemia; data from 515 patients enrolled on the UKALL14 trial
    Mitchell, R.
    Kirkwood, A. A.
    Fearn, A.
    Schwab, C.
    Wrench, B.
    Lawrie, E.
    Alapi, K. Zuborne
    Lee, S.
    Muirhead, R. C. J.
    Clifton-Hadley, L.
    Patrick, P.
    Moorman, A. V.
    Fielding, A. K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 39 - 40
1